These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2257130

  • 1. Acellular and whole cell pertussis vaccines protect against the lethal effects of intracerebral challenge by two different T-cell dependent humoral routes.
    Wiertz EJ, Walvoort HC, Van Loveren H, Van Straaten-Van De Kappelle I, Van Der Gun JW, Kreeftenberg JG.
    Biologicals; 1990 Jul; 18(3):173-80. PubMed ID: 2257130
    [Abstract] [Full Text] [Related]

  • 2. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
    Kimura A, Mountzouros KT, Relman DA, Falkow S, Cowell JL.
    Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
    [Abstract] [Full Text] [Related]

  • 3. Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines.
    Canthaboo C, Williams L, Xing DK, Corbel MJ.
    Vaccine; 2000 Nov 08; 19(6):637-43. PubMed ID: 11090715
    [Abstract] [Full Text] [Related]

  • 4. [Humoral response to the injection of acellular Pertussis vaccine].
    Zakharova NS, Remova TN, Britsina MV, Shmeleva EI, Mertsalova NU, Zaĭtsev EM, Ozeretskovskaia MN, Bazhanova IG, Ermolova EV.
    Zh Mikrobiol Epidemiol Immunobiol; 2001 Nov 08; (6):40-4. PubMed ID: 11881494
    [Abstract] [Full Text] [Related]

  • 5. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H, Sato Y.
    Infect Immun; 1990 Oct 08; 58(10):3369-74. PubMed ID: 1698179
    [Abstract] [Full Text] [Related]

  • 6. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system.
    Sato H, Sato Y.
    Infect Immun; 1984 Nov 08; 46(2):415-21. PubMed ID: 6542069
    [Abstract] [Full Text] [Related]

  • 7. Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model.
    Olander RM, Muotiala A, Karvonen M, Kuronen T, Runeberg-Nyman K.
    Microb Pathog; 1990 Jan 08; 8(1):37-45. PubMed ID: 2159104
    [Abstract] [Full Text] [Related]

  • 8. Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.
    van den Berg BM, David S, Beekhuizen H, Mooi FR, van Furth R.
    Vaccine; 2000 Dec 08; 19(9-10):1118-28. PubMed ID: 11137247
    [Abstract] [Full Text] [Related]

  • 9. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Taniguchi T, Kozuka S, Matano K, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2003 Mar 07; 21(11-12):1165-73. PubMed ID: 12559794
    [Abstract] [Full Text] [Related]

  • 10. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A.
    Dev Biol Stand; 1997 Mar 07; 89():315-20. PubMed ID: 9272365
    [Abstract] [Full Text] [Related]

  • 11. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM, Meade BD, Decker MD, Reed GF, Rennels MB, Steinhoff MC, Anderson EL, Englund JA, Pichichero ME, Deloria MA.
    Pediatrics; 1995 Sep 07; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [Abstract] [Full Text] [Related]

  • 12. Pertussis whole cell vaccine: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin and adenylate cyclase.
    Dellepiane NI, Manghi MA, Eriksson PV, di Paola G, Cangelosi A.
    Zentralbl Bakteriol; 1992 Jun 07; 277(1):65-73. PubMed ID: 1520970
    [Abstract] [Full Text] [Related]

  • 13. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD, Gornbein J, Heininger U, Stehr K.
    Vaccine; 1998 Dec 07; 16(20):1901-6. PubMed ID: 9796041
    [Abstract] [Full Text] [Related]

  • 14. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge.
    Nascimento IP, Dias WO, Quintilio W, Christ AP, Moraes JF, Vancetto MD, Ribeiro-Dos-Santos G, Raw I, Leite LC.
    Microbes Infect; 2008 Feb 07; 10(2):198-202. PubMed ID: 18248757
    [Abstract] [Full Text] [Related]

  • 15. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH.
    BMC Infect Dis; 2017 Apr 04; 17(1):247. PubMed ID: 28376777
    [Abstract] [Full Text] [Related]

  • 16. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H, Sato Y.
    Dev Biol Stand; 1985 Apr 04; 61():461-7. PubMed ID: 2872127
    [Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana.
    Afari EA, Kamiya Y, Nkrumah FK, Dunyo SK, Akpedonu P, Kamiya H, Fukai F.
    Ann Trop Paediatr; 1996 Mar 04; 16(1):39-48. PubMed ID: 8787364
    [Abstract] [Full Text] [Related]

  • 18. Specific immune response in adult medical personnel immunized with acellular pertussis vaccine with special emphasis on T helper cell response.
    Lin TY, Chiang BL.
    Vaccine; 1997 Dec 04; 15(17-18):1917-21. PubMed ID: 9413102
    [Abstract] [Full Text] [Related]

  • 19. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.
    Pediatrics; 1997 Nov 04; 100(5):772-88. PubMed ID: 9346976
    [Abstract] [Full Text] [Related]

  • 20. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y, Sato H.
    Dev Biol Stand; 1985 Nov 04; 61():367-72. PubMed ID: 3835079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.